Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels.

Abstract

Graves' disease (GD) is the leading cause of hyperthyroidism, and the majority of GD patients eventually develop disorders of glucose handling, which further affects their quality of life. Yangxin Tongmai formula (YTF) is modified from a famous formula of traditional Chinese medicine for the treatment of cardiovascular diseases. In this study we investigated the potential effects of YTF in the treatment of pediatric GD patients with impaired glucose tolerance. Forty pediatric GD patients and 20 healthy children were recruited for this clinical study. Based on the glucose tolerance, the GD patients were divided into two groups: 20 patients displayed impaired glucose tolerance, while the other 20 patients displayed normal glucose tolerance. YTF was orally administered for 60 days. YTF administration significantly ameliorated the abnormal glucose tolerance and insulin sensitivity in the GD patients with impaired glucose tolerance. To determine the molecular mechanisms of this observation, the number of plasma insulin receptors was determined by ELISA. Before treatment, the fasting and postprandial levels of the insulin receptor were significantly lower in patients with impaired glucose tolerance compared with those in patients with normal glucose tolerance and healthy children. After YTF treatment, both the fasting and the postprandial circulating insulin receptor levels were upregulated, and close to those in healthy children. Therefore, YTF is a potential effective treatment to enhance glucose handling in GD children with impaired glucose tolerance.

• Authors: Yan-Hong Luo, Min Zhu, Dong-Gang Wang, Yu-Sheng Yang, Tao Tan, Hua Zhu, Jian-Feng He
• Journal: Acta pharmacologica Sinica (Acta Pharmacol Sin) Vol. 39 Issue 6 Pg. 923-929 (Jun 2018) ISSN: 1745-7254 [Electronic] United States
• PMID: 29168473 (Publication Type: Controlled Clinical Trial, Journal Article)

Chemical References

• Antigens, CD
• Biomarkers
• Blood Glucose
• Drugs, Chinese Herbal
• Hypoglycemic Agents
• INSR protein, human
• Receptor, Insulin

Topics

• Adolescent
• Age Factors
• Antigens, CD (blood, drug effects)
• Biomarkers (blood)
• Blood Glucose (drug effects, metabolism)
• Child
• China
• Drugs, Chinese Herbal (adverse effects, therapeutic use)
• Female
• Glucose Intolerance (blood, diagnosis, drug therapy, etiology)
• Graves Disease (complications, diagnosis)
• Humans
• Hypoglycemic Agents (adverse effects, therapeutic use)
• Insulin Resistance
• Male
• Receptor, Insulin (blood, drug effects)
• Time Factors
• Treatment Outcome
• Up-Regulation